Intrexon | Koszty Operacyjne



Operating Expenses Zmiana Data
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
MannKind USD 56.06M 7.61M 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
Veracyte USD 113.31M 1.15M 2025-03
Xencor USD 75.91M 9.94M 2025-03



Intrexon Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.